I Was Early Before But Now Is The Time For TG Therapeutics

by Biotech Newsroom


Word Count: 3,367 words, Reading Time: 15 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.

Subscribers: Substack is telling me this post is too long for email so please load in browser if the bottom cuts off before my signature.

On May 27, 2025 I wrote my first article about TGTX 0.00%↑ TG Therapeutics:

I think everything in the article has aged very well, all things considered. The stock price has not aged that well. When…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC